Stay updated with breaking news from Codexis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wall Street analysts expect that Codexis, Inc. (NASDAQ:CDXS – Get Rating) will report sales of $29.10 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Codexis’ earnings. The highest sales estimate is $31.70 million and the lowest is $27.58 million. Codexis posted sales of $18.03 million during […]
Codexis, Inc. (NASDAQ:CDXS – Get Rating) gapped up prior to trading on Thursday . The stock had previously closed at $20.10, but opened at $20.68. Codexis shares last traded at $20.13, with a volume of 11,329 shares changing hands. A number of equities analysts have recently weighed in on CDXS shares. Cowen started coverage on […]
Shares of Codexis, Inc. (NASDAQ:CDXS – Get Rating) have been given an average rating of “Buy” by the eight brokerages that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have issued a buy recommendation on the company. The average […]
StockNews.com initiated coverage on shares of Codexis (NASDAQ:CDXS – Get Rating) in a report issued on Thursday. The brokerage set a “sell” rating on the biotechnology company’s stock. CDXS has been the subject of a number of other reports. Cowen initiated coverage on Codexis in a research report on Wednesday, March 2nd. They set a […]
Wall Street brokerages expect that Codexis, Inc. (NASDAQ:CDXS – Get Rating) will report $29.60 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for Codexis’ earnings, with estimates ranging from $27.60 million to $31.70 million. Codexis reported sales of $18.03 million during the same quarter last year, which […]